Q2 2024 Aytu Biopharma Inc Earnings Call Transcript
Welcome to the Aytu Biopharma fiscal 2024 Q2 earnings call. At this time, all participants are in a listen only mode. (Operator Instructions) question and answer session will follow the formal presentation. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, [Roger Rice]. You may begin.
Good afternoon, everyone, and thank you for joining us for Aytu Biopharma's fiscal 2024 second quarter financial and operational results. Conference call for the period ended December 31, 2023. Joining us on today's call is Aytu CEO, Josh Disbrow; and the Company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we'll open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today.
Finally, I'd like to call your attention to the safe harbor disclosure
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |